The Enterprise Value as of November 2024 (TTM) for Alterity Therapeutics Limited (ATHE) is 3.39M

According to Alterity Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 3.39M. This represents a change of -99.98% compared to the average of 13.91B of the last 4 quarters.

Alterity Therapeutics Limited (ATHE) Historical Enterprise Value (quarterly & annually)

How has ATHE Enterprise Value performed in the past?

The mean historical Enterprise Value of Alterity Therapeutics Limited over the last ten years is 19.31B. The current 3.39M Enterprise Value has changed -98.24% with respect to the historical average. Over the past ten years (40 quarters), ATHE's Enterprise Value was at its highest in in the September 2014 quarter at 61.89B. The Enterprise Value was at its lowest in in the March 2020 quarter at 5.52B.

Alterity Therapeutics Limited (ATHE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alterity Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alterity Therapeutics Limited (ATHE) Average Enterprise Value

How has ATHE Enterprise Value performed in the past?

The current Enterprise Value of Alterity Therapeutics Limited (ATHE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alterity Therapeutics Limited (ATHE) Enterprise Value vs. Peers

How is ATHE’s Enterprise Value compared to its peers?

Alterity Therapeutics Limited’s Enterprise Value is less than Anebulo Pharmaceuticals, Inc. (45.92M), less than PMV Pharmaceuticals, Inc. (48.13M), less than AN2 Therapeutics, Inc. (5.46M), less than Eliem Therapeutics, Inc. (119.64M), less than HCW Biologics Inc. (25.13M), greater than Protara Therapeutics, Inc. (-31165818.00), less than Vaccinex, Inc. (8.95M), less than Monopar Therapeutics Inc. (81.10M), less than Miromatrix Medical Inc. (90.06M), greater than Surrozen, Inc. (2.49M), less than NovaBay Pharmaceuticals, Inc. (4.95M), greater than ARCA biopharma, Inc. (1.56M), greater than Quoin Pharmaceuticals, Ltd. (3.24M), greater than Artelo Biosciences, Inc. (1.07M), greater than Adial Pharmaceuticals, Inc. (3.15M), less than TransCode Therapeutics, Inc. (5.76M), less than Aditxt, Inc. (12.23M), less than Reviva Pharmaceuticals Holdings, Inc. (28.64M), greater than Avenue Therapeutics, Inc. (-1770008.00),

Build a custom stock screener for Alterity Therapeutics Limited (ATHE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterity Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alterity Therapeutics Limited (ATHE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alterity Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.